(Reuters) -Johnson & Johnson sued the U.S. government on Tuesday, becoming the latest drugmaker seeking to block a program that […]
Teladoc expands Microsoft tie-up to document patient visits with AI
(Reuters) – Teladoc Health is expanding a partnership with Microsoft to use the tech giant’s artificial intelligence services to automate […]
AT&T shares hit three-decade low as lead cables risk weighs
By Chibuike Oguh NEW YORK (Reuters) -Shares of AT&T Inc fell nearly 7% to hit their lowest level in thirty […]
Court blocks curbs on US government contact with social media companies for now
By Brendan Pierson (Reuters) -A U.S. appeals court on Friday temporarily blocked a lower court order that had sharply limited […]
UnitedHealth’s lower-than-feared costs lift profit, shares
By Bhanvi Satija and Raghav Mahobe (Reuters) -UnitedHealth Group’s quarterly profit beat Wall Street estimates on Friday as a smaller-than-expected […]
Eli Lilly to buy Versanis for up to $1.93 billion in obesity drugs push
By Sriparna Roy (Reuters) -Eli Lilly and Co said on Friday it will buy privately held Versanis for potentially up […]
US FDA reviewing concerns over Logan Paul’s PRIME energy drink
(Reuters) – The U.S. Food and Drug Administration said on Wednesday it is reviewing concerns raised by Senate Majority Leader […]